Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy

Código QR

Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy

Habibah Setyawati Muhiddin, Muhammad Irfan Kamaruddin, Andi Muhammad Ichsan, Budu Department of Ophthalmology, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, IndonesiaCorrespondence: Habibah Setyawati Muhiddin Email muhiddinhabibah@yahoo.co.idPurpose: This study aimed to inves...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Muhiddin HS, Kamaruddin MI, Ichsan AM, Budu
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	vascular endothelial growth factor platelet-derived growth factor proliferative diabetic retinopathy fibrotic tissue Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/914782066aab40a8ae4ec467c8478069
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Vitreous concentrations of vascular endothelial growth factor as a potential biomarker for postoperative complications following pars plana vitrectomy
por: Faruk Nisic, et al.
Publicado: (2019)

Efficacy and Safety of Various Treatments for Proliferative Diabetic Retinopathy: A Systematic Review and Network Meta-Analysis
por: Bo Zhang, et al.
Publicado: (2021)

Prospects for the treatment of diabetic retinopathy: Modulation of endothelial growth factor
por: Anatoliy Gennad'evich Kuzmin, et al.
Publicado: (2009)

Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
por: Abu-Yaghi NE, et al.
Publicado: (2020)

Vascular endothelial growth factor in the fluid of the anterior chamber of the eye in patients with diabetic retinopathy, cataract andneovascular glaucoma
por: Anatoliy Gennad'evich Kuz'min, et al.
Publicado: (2010)

The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept
por: Amy S. Babiuch, et al.
Publicado: (2021)

Release of transforming growth factor beta 1 and platelet derived growth factor type AB from canine platelet gels obtained by the tube method and activated with calcium salts
por: Silva,RF, et al.
Publicado: (2013)

Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment
por: Leley SP, et al.
Publicado: (2021)

Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells
por: Jun JH, et al.
Publicado: (2016)

Immunohistochemical Localization of Vascular Factors in Tooth Germ of Amphibian (Cynops pyrrhogaster)
por: Miwa,Yoko, et al.
Publicado: (2021)

Growth factors in the treatment of diabetic foot syndrome
por: Elena Y. Komelyagina, et al.
Publicado: (2019)

The Effect of STAT3 Signal Pathway Activation on Retinopathy of Prematurity
por: Jianbing Ren, et al.
Publicado: (2021)

Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy
por: Sakamoto M, et al.
Publicado: (2018)

Vascular Endothelial Growth Factor as a Putative Biomarker of Depression in Asthmatics with Reversible Airway Narrowing
por: Krzysztof Gomułka, et al.
Publicado: (2021)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan CS, et al.
Publicado: (2017)

Vascular Endothelial Growth Factor in Unstimulated Saliva of the Patients with Minor Aphtha
por: S Seifi,, et al.
Publicado: (2012)

Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization
por: Lee JE, et al.
Publicado: (2017)

Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy
por: Sakamoto M, et al.
Publicado: (2018)

EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
por: O. M. Trubina, et al.
Publicado: (2016)

Assessment of growth factors with three different platelet preparations, namely platelet-rich fibrin, platelet-rich plasma, and lyophilized platelet: An In vitro study
por: R Hariprasad, et al.
Publicado: (2021)

Vascular Endothelial Growth Factor Expression in Correlation with Stage Juvenile Nasopharyngeal Angiofibroma
por: Ifiq Budiyan Nazar, et al.
Publicado: (2021)

A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics
por: Xiaoqing Ye, et al.
Publicado: (2021)

Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury
por: Kamilla Faritovna Idrisova, et al.
Publicado: (2022)

Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study
por: Jhingan M, et al.
Publicado: (2018)

Platelet-rich fibrin: Basics of biological actions and protocol modifications
por: Pavlovic Voja, et al.
Publicado: (2021)

Sauromatum guttatum extract promotes wound healing and tissue regeneration in a burn mouse model via up-regulation of growth factors
por: Ali Said, et al.
Publicado: (2019)

Growth factors
Publicado: (1988)

Visual evoked potentials after panretinal photocoagulation in patients with proliferative diabetic retinopathy
por: Amini Vishte R, et al.
Publicado: (2019)

Relationship Between Fibroblast Growth Factor 19 and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
por: Chung JO, et al.
Publicado: (2021)

Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoingin vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study
por: Niyazi Kilic, et al.
Publicado: (2015)

Actualización en el diagnóstico y terapéutica en hipertensión pulmonar arterial
por: Zagolin B,Mónica, et al.
Publicado: (2006)

Effects of Xylene on Respiratory Mucosa in Rats
por: Arslan,Eda, et al.
Publicado: (2016)

Expression of Platelet Derived Growth Factor a, Its Receptor, and Integrin Subunit Alpha V in Feline Injection-Site Sarcomas
por: Ahmed Ishtiaq, et al.
Publicado: (2021)

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
por: Blinder KJ, et al.
Publicado: (2017)

Identificación de factor de crecimiento vascular endotelial en células glandulares de tejido prostético maligno y benigno: Relación con la recidiva tumoral al año de la prostatectomía
por: Acuña,Pedro, et al.
Publicado: (2013)

Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
por: Wingard JB, et al.
Publicado: (2019)

Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia‐inducible factor‐1α in colorectal cancer
por: Chao Fang, et al.
Publicado: (2021)

Relationship between vascular endothelial growth factor and macular edema in retinal vein branch obstruction
por: Okawada H, et al.
Publicado: (2018)

Evaluation of the Safety of Bilateral Same-Day Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents: Experience of a Large Korean Retina Center
por: Jang K, et al.
Publicado: (2020)

Platelet-functionalized three-dimensional poly-ε-caprolactone fibrous scaffold prepared using centrifugal spinning for delivery of growth factors
por: Rampichová M, et al.
Publicado: (2017)